Prognostic value of a history of hypertension in 11483 patients with acute myocardial infarction treated with thrombolysis

Journal of Hypertension

Volumn 14, Issue 6, 1996, Pages 743-750

  Fresco, Claudio ^a   Avanzini, Fausto ^b   Bosi, Stefano ^a   Franzosi, Maria Grazia ^b   Maggioni, Aldo P ^b   Santoro, Luigi ^b   Bellanti, Giancarlo ^a  

^a Istituto di Ematologia   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Acute myocardial infarction; Arterial hypertension; Prognostic factor

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030011631     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199606000-00010     Document Type: Article

References (34)

1. The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis 1978, 31:201-306.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
3. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risk. US population data. Arch Intern Med 1993, 153:598-615.
4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al.: Blood pressure, stroke, and coronary heart disease. Part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335:827-838.
5. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH: Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993, 153:578-581.
6. Pell S, D'Alonzo CA: Immediate mortality and five-year survival of employed men with a first myocardial infarction. N Engl J Med 1964, 270:915-922.
7. Norris RM, Bensley KE, Caughey DE, Scott PJ: Hospital mortality in acute myocardial infarction. BMJ 1968, 3:143-146.
8. Norris RM, Caughey DE, Mercer CJ, Scott PJ: Prognosis after myocardial infarction. Six year follow-up. Br Heart J 1974, 36:786-790.
9. Helmers C: Assessment of 3-year prognosis in survivors of acute myocardial infarction. Br Heart J 1975, 37:593-597.
10. Kitchin AH, Pocock SJ: Prognosis of patients with acute myocardial infarction admitted to a coronary care unit I: survival in hospital. Br Heart J 1977, 39:1163-1166.
11. Kitchin AH, Pocock SJ: Prognosis of patients with acute myocardial infarction admitted to a coronary unit. II: survival after hospital discharge. Br Heart J 1977, 39:1167-1171.
12. Rabkin SW, Mathewson FAL, Tate RB: Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol 1977, 40:604-610.
13. Henning R, Lundman T, Swedish Co-operative CCU Study: A study of 2008 patients with acute myocardial infarction from twelve Swedish hospitals with coronary care unit. Part I: a description of the early stage. Acta Med Scand Suppl 1977, (suppl 586):1-64.
14. Henning R, Swedish Co-operative CCU Study: A study of 2008 patients with acute myocardial infarction from twelve Swedish hospitals with coronary care unit. Part II: the short-term prognosis. Acta Med Scand Suppl 1977, (suppl 586):1-35.
15. Bigger JT, Heller CA, Wenger TL, Weld FM: Risk stratification after acute myocardial infarction. Am J Cardiol 1978, 42:202-210.
16. Taylor GJ, Humphries JON, Mellits ED, Pitt B, Schulze RA, Griffith LSC, et al.: Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 1980, 62:960-970.
17. Kannel WB, Sorlie P, Castelli WP, McGee D: Blood pressure and survival after myocardial infarction: the Framingham study. Am J Cardiol 1980, 45:326-330.
18. Henning R, Wedel H: The long-term prognosis after myocardial infarction: a five-year follow-up study. Eur Heart J 1981, 2:65-74.
19. Martin CA, Thompson PL, Armstrong BK, Hobbs MST, de Klerk N: Long-term prognosis after recovery from myocardial infarction: a nine-year follow-up of the Perth Coronary Register. Circulation, 1983, 68:961-969.
20. Rapaport E, Remedios F: The high risk patient after recovery from myocardial infarction: recognition and management. J Am Coll Cardiol 1983, 1:391-400.
21. Greco R, Greco L, Siciliano S, D'Alterio D, Gentile F, Di Cresce P, et al.: Sopravvivenza a 10 anni dopo l'infarto del miocardio. Studio longitudinale su una popolazione ospedaliera. G Ital Cardiol 1984, 14:1015-1024.
22. Cleempoel H, Vainsel H, Dramaix M, Lenaers A, Contu E, Hoylaerts M, et al.: Limitations on the prognostic value of predischarge data after myocardial infarction. Br Heart J 1988, 60:98-103.
23. Maeland JG, Meen K: Predicting long-term mortality after myocardial infarction from routine hospital data. Acta Med Scand 1988, 224:539-547.
24. De Martini M, Velentini R, Cesana B, Massari FM, Lettino M, Pupilella T, et al.: La prognosi precoce e tardiva nell'infarto miocardico acuto. Studio retrospettivo in pazienti ricoverati in unità coronarica negli ultimi dieci anni. G Ital Cardiol 1990, 20:215-226.
25. Herlitz J, Karlson BW, Richter A, Wiklund O, Jablonskiene D, Hjalmarson A: Prognosis in hypertensives with acute myocardial infarction. J Hypertens 1992, 10:1265-1271.
26. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin in among 12490 patients with acute myocardial infarction. Lancet 1990, 336:65-71.
27. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, et al.: Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysls. Results of the GISSI-2 data-base. Circulation 1993, 88:416-429.
28. Mauri F, Maggioni AP, Franzosi MG, De Vita C, Santoro E, Santoro L, et al.: A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-derived analysis. J Am Coll Cardiol 1994, 24:600-607.
29. Wong ND, Cupples LA, Ostfeld AM, Levy D, Kannel WB: Risk factors for long-term coronary prognosis after initial myocardial infarction: The Framingham Study. Am J Epidemiol 1989, 130:469-480.
30. The Coronary Drug Project Research Group: Blood pressure in survivors of myocardial infarction. J Am Coll Cardiol 1984, 4:1135-1147.
31. Cruikshank JM, Thorp JM, Zacharias FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1987, 1:581-584.
32. D'Agostino RB, Belanger AJ, Kannel WB, Cruikshank JM: Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham study. BMJ 1991, 303:385-389.
33. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR: The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991, 265:489-495.
34. The HOT Study Group: The hypertension optimal treatment study (The HOT-Study). Blood Pressure 1993, 2:62-68.